Tirzepatide for Sale — Research-Grade, Third-Party Tested
Looking to buy Tirzepatide? MyGLP1Store offers Tirzepatide (TIRZ) for sale as a third-party lab-tested research peptide sourced direct from the manufacturer, with documented >99% purity and same-day U.S. shipping. Veteran-owned and trusted by researchers (Trustpilot 4.8). For laboratory research use only.
TIRZ — Tirzepatide (Lyophilized Research Peptide, 5mg–120mg)
TIRZ (Tirzepatide) is a dual GIP and GLP-1 receptor agonist peptide studied in metabolic and endocrinology research models. It is widely explored for its combined action on glucose-dependent insulin secretion and appetite-related signaling pathways.
Due to its dual-receptor activity, Tirzepatide is commonly investigated in research focused on metabolic efficiency, glucose control mechanisms, and energy balance regulation. For background on how these receptor pathways are studied, see our tirzepatide research guide and our overview of GLP-1 research peptides.
Tirzepatide Specifications
| Peptide | Tirzepatide (TIRZ) |
| CAS Number | 2023788-19-2 |
| Molecular Formula | C₂₂₅H₃₄₈N₄₈O₆₈ |
| Molecular Weight | ~4813.5 g/mol |
| Receptor Class | Dual agonist (GIP receptor + GLP-1 receptor) |
| Purity | >99% (third-party verified) |
| Form | Lyophilized powder |
| Vial Sizes | 5mg, 10mg, 15mg, 20mg, 30mg, 60mg, 120mg |
| Storage | Store at -20°C; after reconstitution, refrigerate at 2–8°C and use within 30 days (reconstitution method) |
Potential Research Applications:
- Metabolic pathway and glucose regulation studies
- GIP and GLP-1 receptor interaction research
- Energy balance and appetite signaling models
- Insulin response and endocrine function investigations
How Tirzepatide Compares to Other GLP-1 Research Peptides
Tirzepatide is a dual agonist acting on the GIP and GLP-1 receptors — one more pathway than semaglutide (GLP-1 only) and one fewer than retatrutide (GLP-1/GIP/glucagon). For a side-by-side of dose ranges and trial outcomes, see semaglutide vs tirzepatide.
| Compound | Receptor Targets | Research Class |
|---|---|---|
| Tirzepatide (TIRZ) | GLP-1 + GIP | Dual agonist |
| Semaglutide (SEMA) | GLP-1 | Single agonist |
| Retatrutide (RETA) | GLP-1 + GIP + Glucagon | Triple agonist |
Selected Research Literature
Tirzepatide is among the most heavily published dual-incretin agonists in metabolic research. Representative peer-reviewed reading:
- Jastreboff AM, et al. — SURMOUNT-1: tirzepatide once weekly in adults with obesity. [PubMed]
- Frías JP, et al. — SURPASS-2: tirzepatide versus semaglutide in type 2 diabetes. [PubMed]
- Coskun T, et al. — preclinical characterization of LY3298176 (tirzepatide) as a dual GIP/GLP-1 receptor agonist. [PubMed]
Tirzepatide (TIRZ) — Frequently Asked Questions
Where can I buy tirzepatide research peptide?
You can buy the tirzepatide research peptide directly from MyGLP1Store in vial sizes from 5mg to 120mg. Every batch is third-party tested and ships same-day from the US. For laboratory research use only.
What is TIRZ?
TIRZ is the abbreviation for Tirzepatide, a dual GIP and GLP-1 receptor agonist peptide studied in metabolic and endocrinology research. MyGLP1Store supplies TIRZ as a lyophilized research peptide for laboratory use only.
Is TIRZ the same as Tirzepatide?
Yes. TIRZ is simply the short form of Tirzepatide used by researchers — it is the same dual-agonist research peptide.
Is TIRZ third-party tested?
Yes — every batch is third-party lab tested for purity and identity before release, at documented >99% purity.
What other GLP-1 research peptides does MyGLP1Store offer?
Researchers studying TIRZ often also work with Cagrilintide (CAGRI), Semaglutide (SEMA), Retatrutide (RETA), and other compounds in our obesity research collection.
For laboratory and research use only. Not for human or veterinary consumption. Nothing on this page is medical advice or a dosing recommendation.
Related Research Compounds
Tirzepatide (TIRZ) is commonly compared against other incretin and metabolic research peptides. Explore related third-party tested lyophilized compounds:
- Buy Retatrutide (RETA) — triple GIP/GLP-1/glucagon receptor agonist.
- Semaglutide (SEMA) — GLP-1 receptor agonist research peptide.
- Cagrilintide peptide (CAGRI) — long-acting amylin analog research compound.
- Cagrilintide + Semaglutide blend — dual-peptide metabolic research combination.
Tirzepatide — Further Research Reading
Background methodology and comparative data from our research library:
- Tirzepatide research guide — dual GIP/GLP-1 mechanism and published SURPASS/SURMOUNT data.
- Semaglutide vs tirzepatide — head-to-head dose comparison and trial outcomes.
- Semaglutide research guide — the single-agonist comparator used across the literature.
- Quality standards in GLP-1 research — how laboratories evaluate purity and analytical documentation.
- About our research lead — who reviews the analytical data behind every lot.





Anonymous –
The shipping is always fast and good customer service
Jay –
Everything’s always as advertised and delivered quickly
Tiffany Pruitt –
Fast delivery.
RACHEL –
Package arrived quickly and contained all needed supplies. I have not used the peptides yet, but I am impressed with communication I received and great packaging.
Kristina S. –
Brittani Parish –
Amber Roberts –
Fast shipping and love that everything I need is included!
Jody Olson –
KELLY L. –
Although I have not tried my peptide yet, I am excited. Everything arrived promptly. Unlike other peptide companies I was pleasantly surprised, they sent syringes and biostatic water for reconstituting. I also love as a company they donate a portion of my purchase price to animal organizations. Looking forward to purchasing from them again.
Patrick –
Kimberly G. –
The shipping was quick. I had questions so I called the number and left a message. I received a text within minutes and was talked through my questions. Amazing customer service.
Anonymous –
Love the product and it arrives fast!